Medicine and Dentistry
Adjuvant Therapy
9%
Anastrozole
11%
Aromatase Inhibitor
5%
Biological Marker
11%
BRCA1
37%
BRCA2
14%
Breast Cancer
6%
Cancer Cell
8%
Cancer Risk
10%
Carcinosarcoma
6%
Cervical Cancer
10%
Clinician
8%
Cohort Analysis
8%
Diseases
22%
DNA Damage Response
8%
DNA Repair
7%
Endometrial Cancer
43%
Estrogen Receptor
8%
Ex Vivo
8%
Female Genital Tract Cancer
26%
Fibroblast Growth Factor Receptor 2
5%
Gynecological Oncology
7%
Homologous Recombination
14%
Hormone Therapy
5%
Krukenberg Tumor
49%
Levonorgestrel
5%
Logistic Regression Analysis
7%
Malignant Neoplasm
35%
Neoadjuvant Chemotherapy
5%
Neoplasm
22%
Observational Study
6%
Ovarian Cancer
100%
Ovarian Cancer Cell Line
6%
Ovarian Tumor
5%
Overall Survival
11%
PARP Inhibitor
17%
Progesterone
8%
Progesterone Receptor
9%
Prognostic Factor
6%
Progression Free Survival
10%
Protein P53
12%
Radiation Therapy
5%
Recurrent Disease
9%
Rucaparib
6%
Salpingooophorectomy
8%
Somatics
6%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
11%
Disease
11%
Endometrium Cancer
11%
Fibroblast Growth Factor Receptor 2
5%
Malignant Neoplasm
13%
Neoplasm
12%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
10%
Ovary Cancer
35%
Ovary Carcinoma
12%
Ovary Tumor
6%
Primary Culture
9%
Rucaparib
6%
Biochemistry, Genetics and Molecular Biology
BRCA1
16%
DNA Damage Response
5%
Germ Cell
11%
Germline
11%
Homologous Recombination
12%
Single-Nucleotide Polymorphism
6%
